JSR

Kroll Settlement Administration Announces That a Proposed Class Action Settlement Has Been Reached in the Lawsuit Steamship Trade Association of Baltimore – International Longshoremen’s Association Pension Fund V. Olo Inc.

Retrieved on: 
torsdag, mars 14, 2024

The following statement is being issued by Kroll Settlement Administration regarding Steamship Trade Association of Baltimore – International Longshoremen’s Association Pension Fund v. Olo Inc., 22-CV-8228 (JSR) (S.D.N.Y.).

Key Points: 
  • The following statement is being issued by Kroll Settlement Administration regarding Steamship Trade Association of Baltimore – International Longshoremen’s Association Pension Fund v. Olo Inc., 22-CV-8228 (JSR) (S.D.N.Y.).
  • TO: ALL PERSONS AND ENTITIES THAT PURCHASED OR OTHERWISE ACQUIRED SHARES OF THE CLASS A COMMON STOCK (“COMMON STOCK”) OF OLO INC. (“OLO”) BETWEEN MARCH 17, 2021 AND AUGUST 11, 2022, INCLUSIVE (THE “CLASS”).
  • The Court may change the date of the Settlement Hearing without providing another notice.
  • You do NOT need to attend the Settlement Hearing in order to receive a distribution from the Net Settlement Fund.

TSMC’s Kumamoto Plant (JASM) Grand Opening on 24th February, Poised to Shape Japan’s Semiconductor Landscape Over the Next Decade, Says TrendForce

Retrieved on: 
fredag, februari 23, 2024

This figure is expected to climb to around $131.65 billion in 2024, increasing TSMC’s share to 62%.

Key Points: 
  • This figure is expected to climb to around $131.65 billion in 2024, increasing TSMC’s share to 62%.
  • The much-anticipated opening of TSMC’s Kumamoto Plant (JASM) in Japan on the 24th marks TSMC’s debut factory in Japan (Fab-23), signaling a bold step into the future.
  • TrendForce envisions Japan developing three semiconductor powerhouses in Kyushu, Tohoku, and Hokkaido, with Kyushu taking the lead, especially as the home of TSMC’s Kumamoto plant.
  • With concerted efforts from industry, government, and academia, Japan is on the brink of creating a comprehensive semiconductor manufacturing ecosystem.

KBI Biopharma, Inc. Continues to Strengthen Leadership and Expertise With Key Executive Appointments

Retrieved on: 
torsdag, augusti 10, 2023

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments to continue its momentum and vision of becoming a next-generation CDMO.

Key Points: 
  • KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments to continue its momentum and vision of becoming a next-generation CDMO.
  • “I am thrilled to welcome these four exceptional experts to KBI.
  • As KBI’s Chief of Staff, Seth is a seasoned business and technology executive who excels at driving operational execution and performance.
  • With a proven record of success, she will contribute valuable leadership skills in executive strategy, marketing, branding and identity, DEI initiatives, project management, and organizational and team development.

KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO

Retrieved on: 
måndag, april 17, 2023

KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, today announced the appointment of J.D.

Key Points: 
  • KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, today announced the appointment of J.D.
  • will lead KBI and Selexis into the next chapter of becoming a leader in the next generation of CDMOs that are emerging.
  • Mowery, KBI Biopharma and Selexis SA Chief Executive Officer (Photo: Business Wire)
    “Through decades of service, J.D.
  • will play a crucial role in leading KBI and Selexis and empowering our global teams to succeed through servant leadership.

MetaVC Partners Raises $62 Million Fund to Invest in Hard-Tech Metamaterials Startups

Retrieved on: 
onsdag, april 12, 2023

SAN FRANCISCO, April 12, 2023 /PRNewswire/ -- MetaVC Partners today announced the close of MetaVC Partners, LLC., a $62 million fund that will invest in early-stage, hard-tech metamaterials startup companies.

Key Points: 
  • SAN FRANCISCO, April 12, 2023 /PRNewswire/ -- MetaVC Partners today announced the close of MetaVC Partners, LLC., a $62 million fund that will invest in early-stage, hard-tech metamaterials startup companies.
  • Investors in the fund include Corning Inc., Gates Frontier, JSR Corporation along with other family wealth offices and institutional pension funds.
  • MetaVC Partners Raises $62M to Invest in Hard-Tech Metamaterials.
  • Among MetaVC Partners' current investments:
    Lumotive uses the physics of metamaterials to produce tiny semiconductor scanning sensors for anti-collision systems and consumer electronics applications.

In a World First, Yokogawa’s Autonomous Control AI Is Officially Adopted for Use at an ENEOS Materials Chemical Plant

Retrieved on: 
torsdag, mars 30, 2023

This is the first example in the world of reinforcement learning AI being formally adopted for direct control of a plant*2.

Key Points: 
  • This is the first example in the world of reinforcement learning AI being formally adopted for direct control of a plant*2.
  • By eliminating the production of off-spec products, the autonomous control AI reduced fuel, labor, and other costs, and made efficient use of raw materials.
  • While producing good quality products that met shipment standards, the autonomous control AI reduced steam consumption and CO2 emissions by 40%*4 in comparison to conventional manual control.
  • To promote plant autonomization, on February 27 Yokogawa launched the provision of an autonomous control AI service for edge controllers*5, also a world first*6.

Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs Targeting Cancer and Autoimmune Diseases

Retrieved on: 
tisdag, februari 14, 2023

JSR Life Sciences, LLC (“JSR”) today announced that Similis Bio (“Similis”), its business unit focused on biosimilar development, has announced plans to enter into a partnership with Novel351k to co-develop three biosimilar programs that address a wide range of hard-to-treat diseases.

Key Points: 
  • JSR Life Sciences, LLC (“JSR”) today announced that Similis Bio (“Similis”), its business unit focused on biosimilar development, has announced plans to enter into a partnership with Novel351k to co-develop three biosimilar programs that address a wide range of hard-to-treat diseases.
  • Under the initial agreement, Similis will be responsible for cell line development, analytics, process development, and cGMP production, leading to pharmacokinetics/pharmacodynamic clinical trials.
  • Novel351k will leverage its experience with regulatory and clinical strategies to accelerate the development of the programs toward commercialization.
  • We look forward to partnering with Similis Bio and JSR to support our goal of improving patients' lives worldwide.”

Global Quantum Computing Market to Reach $4.67 Billion by 2030: Cognitive Market Research

Retrieved on: 
tisdag, februari 14, 2023

CHICAGO, Feb. 14, 2023 /PRNewswire/ -- The Global Quantum Computing Market size is projected to be USD 4.67 Billion by 2030 growing at a CAGR of 32.5% from 2023 to 2030, as per a recent market report published by Cognitive Market Research.

Key Points: 
  • CHICAGO, Feb. 14, 2023 /PRNewswire/ -- The Global Quantum Computing Market size is projected to be USD 4.67 Billion by 2030 growing at a CAGR of 32.5% from 2023 to 2030, as per a recent market report published by Cognitive Market Research.
  • Increased investment in quantum computing and increased numerous strategic partnerships and collaborations among key suppliers is expected to drive growth of this market.
  • For instance, in July 2022, JSR and Quantinuum will cooperate to carry out research on the application of quantum computing in the semiconductor industry.
  • The BFSI segment is expected to hold the highest market share during the quantum computing market forecast period
    North America dominates the global quantum computing market and will maintain its market position over the forecast period.

Global Quantum Computing Market to Reach $4.67 Billion by 2030: Cognitive Market Research

Retrieved on: 
tisdag, februari 14, 2023

CHICAGO, Feb. 14, 2023 /PRNewswire/ -- The Global Quantum Computing Market size is projected to be USD 4.67 Billion by 2030 growing at a CAGR of 32.5% from 2023 to 2030, as per a recent market report published by Cognitive Market Research.

Key Points: 
  • CHICAGO, Feb. 14, 2023 /PRNewswire/ -- The Global Quantum Computing Market size is projected to be USD 4.67 Billion by 2030 growing at a CAGR of 32.5% from 2023 to 2030, as per a recent market report published by Cognitive Market Research.
  • Increased investment in quantum computing and increased numerous strategic partnerships and collaborations among key suppliers is expected to drive growth of this market.
  • For instance, in July 2022, JSR and Quantinuum will cooperate to carry out research on the application of quantum computing in the semiconductor industry.
  • The BFSI segment is expected to hold the highest market share during the quantum computing market forecast period
    North America dominates the global quantum computing market and will maintain its market position over the forecast period.

The global next-generation lithography materials market is projected to reach $1,005.3 million by 2031 from $85.7 million in 2021, growing at a CAGR of 29.46% during the forecast period 2022-2031

Retrieved on: 
tisdag, januari 3, 2023

Key Points: 
  • The global next-generation lithography materials market is estimated to be led by photoresist material.
  • This is expected to expand JSR Group’s business activities in the Chinese market relating to semiconductor materials.
  • Product/Innovation Strategy: The product segment helps the reader understand the technology used in manufacturing next-generation lithography materials, including photoresist and ancillary material.
  • The favored strategy for the companies has been expansion and collaboration to strengthen their position in the next-generation lithography materials market.